Among men with prostate cancer that has stopped responding to hormonal therapy, the bone drug Xgeva™ (denosumab) delayed the spread of cancer to the bones. These results were recently published in The Lancet, and were previously presented at the 2011 European Multidisciplinary Cancer Conference. Androgen deprivation therapy (ADT) often plays an important role in the [...]
For men with locally advanced or high-risk prostate cancer, treatment with a combination of radiation therapy and hormone therapy appears to be more effective than hormone therapy alone. These results were published in The Lancet. Locally advanced prostate cancer refers to cancer that has spread through the prostate capsule but not to distant sites in [...]
Live Web Chat with Barrie R. Cassileth, PhD, Chief, Integrative Medicine Service; Laurance S. Rockefeller Chair Integrative Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), click here for Dr. Cassileth’s bio Dr. Cassileth is a world-renowned authority in intergrated medicine. She is a researcher, educator, and planner who has worked in alternative and complementary (integrative) medicine and [...]
The results of a large, randomized trial suggest that taking daily vitamin E supplements may increase a man’s risk of prostate cancer. These results were published in the Journal of the American Medical Association. Prostate cancer is the most commonly diagnosed type of cancer (other than skin cancer) in US men. Although many prostate cancers [...]
Delivering a shorter course of external-beam radiation therapy—with higher doses of radiation given at each visit—appears to be as effective for prostate cancer as the conventional approach to external-beam radiation therapy. These results were presented at the 53rd Annual Meeting of the American Society for Radiation Oncology (ASTRO). Prostate cancer is the most commonly diagnosed [...]
